Efficacy and safety of finerenone in diabetic kidney disease: Latin American experience from FINDKDLATAM trial

20260 citationsJournal Articlediamond Open Access

Authors

Rodrigo Daza Arnedo · American Society of Nephrology

Vicente Sánchez Polo · Universidad de San Carlos de Guatemala

Jenniffer Benavides Garcia · American Society of Nephrology

Juan Felipe Gutiérrez · Colorado Kidney Care

Enrique Ramos Clason · Universidad Tecnológica de Bolívar

Daniela Domínguez · American Society of Nephrology

Giovany Mera Rebutti

Abstract

In our cohort of patients with CKD associated with T2DM, finerenone proved to be an effective short-term therapy for reducing albuminuria, demonstrating very good tolerance and a low risk of hyperkalemia.

Topics & Keywords

Hormonal Regulation and Hypertension Blood Pressure and Hypertension Studies Adrenal Hormones and Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: World Journal of Nephrology

Volume 15, Issue 1, pp. 115933-115933

DOI: 10.5527/wjn.v15.i1.115933

Field-Weighted Citation Impact: 0.00